Docebo Inc.
NASDAQ:DCBOSoftware - Application
+$0.36 today
- Market cap
- $724.48M
- Beta
- 0.76
- P/E (TTM)
- 14.0
- EPS (TTM)
- $1.23
Volume 0.08M
Average 0.15M
DCBO EBITDA
Earnings before interest, taxes, depreciation, and amortization; a proxy for operating profit before non-cash and financing charges.
Docebo Inc.NASDAQ: DCBO
EBITDA · Q1 FY2026 · quarter ended Mar 2026
EBITDA dips below year-ago levels
Q1 FY2026 EBITDA of $641K fell 79.9% year over year, behind the +1.6% change in trailing-twelve-month EBITDA. Sequentially, it fell 93.6% from the prior quarter. Over 3 fiscal years it compounded at +38.3% a year.
Context
- EBITDA amounted to 11.4% of revenue in FY2025, down 1.1 pp from a year earlier.
- EBITDA increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether EBITDA reaches the consensus estimate from 7 analysts of $56.58M (+103.7%) for the fiscal year ending Dec 2026, a step up from the +1.8% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterMar 2026
- $641K-93.6% QoQ
- Last fiscal yearDec 2025
- $27.78M+1.8% YoY
- LTMMar 2026
- $25.23M+1.6% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | -79.9% | +98.9% | +178.8 pp |
| 1 year | +1.8% | +103.7% | +101.9 pp |
| 3-year CAGR | +38.3% | +64.8% | +26.4 pp |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EBITDA history
USD · from the income statement
- Latest · FY2025
- 27.78M USD
- Year-over-year change
- +1.8%
| Period | Period end | EBITDA | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 27.78M | +1.8% |
| FY2024 | 2024-12-31 | 27.28M | +229.4% |
| FY2023 | 2023-12-31 | 8.28M | -21.0% |
| FY2022 | 2022-12-31 | 10.49M | +196.1% |
| FY2021 | 2021-12-31 | (10.92M) | — |
EBITDA vs competitors
How DCBO compares with its peers on the latest reported figures
- DCBO's LTM Mar 2026 EBITDA of $25.23M is the 2nd highest of the 3 companies compared; the peer median is $2.01M.
- Its year-over-year change of +1.6% is the 2nd highest of 3, against a peer median of +9.4%.
- EBITDA amounts to 10.1% of revenue for DCBO, versus a peer median of 17.7%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Apr 2026 | $49.42M | -9.6% | — | 10.2% | |
| LTM Mar 2026 | $25.23M | +1.6% | +38.3% | 10.1% | |
| LTM Mar 2026 | -$45.39M | +28.4% | — | 25.2% | |
| Peer median (excluding DCBO) | $2.01M | +9.4% | — | 17.7% | |
Competitors are the stored peer set for DCBO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 104.24M | 142.91M | 180.84M | 216.93M | 242.69M |
| Cost of Revenue | 20.79M | 28.18M | 34.5M | 41.3M | 47.85M |
| Gross Profit | 83.46M | 114.73M | 146.34M | 175.64M | 194.84M |
| Gross Margin | 80.1% | 80.3% | 80.9% | 81.0% | 80.3% |
| Research & Development | 20.36M | 24.78M | 35.48M | 43.91M | 50.12M |
| Selling, General & Admin | 74.05M | 94.55M | 107.04M | 109.44M | 117.05M |
| Operating Expenses | 96.91M | 110.55M | 150.05M | 156.73M | 170.36M |
| Depreciation & Amortization | 2.02M | 2.33M | 3.14M | 3.38M | 3.19M |
| EBITDA | (10.92M) | 10.49M | 8.28M | 27.28M | 27.78M |
| EBITDA Margin | -10.5% | 7.3% | 4.6% | 12.6% | 11.4% |
| Operating Income | (13.45M) | 4.19M | (3.71M) | 18.91M | 24.48M |
| Operating Margin | -12.9% | 2.9% | -2.1% | 8.7% | 10.1% |
| Interest Income | 433.15K | 3.76M | 8.11M | 2.55M | 1.86M |
| Interest Expense | 425.23K | 278.51K | 297.35K | 222.76K | 146K |
| Other Income / Expenses | 20K | 3.6M | 8.56M | 4.81M | (34K) |
| Income Before Tax | (13.43M) | 7.78M | 4.85M | 23.71M | 24.45M |
| Pre-Tax Margin | -12.9% | 5.4% | 2.7% | 10.9% | 10.1% |
| Income Tax Expense | 172K | 764K | 2.01M | (3.02M) | (13.07M) |
| Net Income | (13.6M) | 7.02M | 2.84M | 26.74M | 37.51M |
| Net Margin | -13.0% | 4.9% | 1.6% | 12.3% | 15.5% |
| EPS (Basic) | (0.41) | 0.20 | 0.09 | 0.88 | 1.33 |
| EPS (Diluted) | (0.41) | 0.20 | 0.08 | 0.86 | 1.30 |
| Weighted Avg Shares | 32.87M | 33.07M | 32.53M | 30.22M | 28.69M |
| Weighted Avg Shares (Diluted) | 32.87M | 34.04M | 33.68M | 30.94M | 29.37M |
Docebo Inc.
NASDAQ:DCBO
Intrinsic Alpha fair value
Locked
Current Price
$29.04
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.